HEALTHCARE CAPITAL CORP-CL A (HCCC)

Common Stock

12.74  +1.24 (+10.78%)

After market: 13.75 +1.01 (+7.93%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

HEALTHCARE CAPITAL CORP-CL A

NASDAQ:HCCC (3/7/2022, 8:12:28 PM)

After market: 13.75 +1.01 (+7.93%)

12.74

+1.24 (+10.78%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorN/A
GICS IndustryN/A
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month29.21%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap438.00M
Shares
PE79.63
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

HCCC Daily chart

Company Profile

Healthcare Capital Corp is a US-based company operating in industry. The company is headquartered in Wilmington, Delaware. The company went IPO on 2021-01-20. Healthcare Capital Corp is a blank check company. The firm is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company intends to identify businesses across the healthcare industry, with a focus on digital and telehealth, life sciences, medical devices and healthcare technology. The company has conducted no operations and has generated no revenues.

Company Info

HEALTHCARE CAPITAL CORP-CL A

301 N. Market Street Ste 1414

Wilmington DELAWARE 19801

P: 15618100031.0

CEO: William Johns

Employees: 0

HCCC News

News Image3 years ago - Alpha Tau MedicalAlpha Tau Medical and Healthcare Capital Corp. Announce Completion of Business Combination

/PRNewswire/ -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, and Healthcare Capital Corp....

News Image3 years ago - Alpha Tau MedicalAlpha Tau Announces New Research Collaboration to Study the Potential of Alpha DaRT to Enhance Immune Stimulation in the Treatment of Breast Cancer

/PRNewswire/ -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that it has...

News Image3 years ago - Alpha Tau MedicalAlpha Tau Announces Results of First US Clinical Trial of Alpha DaRT™ in Malignant Skin & Soft Tissue Cancers, Showing Complete Response in All Ten Treated Tumors at Approximately 12 Weeks and No Product-Related Serious Adverse Events

/PRNewswire/ -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that all ten...

News Image3 years ago - Alpha Tau MedicalAlpha Tau Announces Enrollment of First Patient in Combination Trial of Alpha DaRT™ and Pembrolizumab (Keytruda®)

/PRNewswire/ -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, announced today that it has...

News Image3 years ago - Moore Kuehn, PLLCMoore Kuehn Encourages CND, HCAQ, HCCC and FPAC Investors to Contact Law Firm
News Image3 years ago - Alpha Tau Medical; Healthcare Capital CorpAlpha Tau and Healthcare Capital Corp. to Combine and Create A Publicly Traded Company Focused on Transforming the Treatment of Solid Tumors Through the Precision Delivery of Alpha Radiation

HCCC Twits

Here you can normally see the latest stock twits on HCCC, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example